We have previously shown that transgenic expression of Id1 under the control of the lck proximal promoter leads to the formation of T cell lymphoma in the thymus with high penetrance and a median survival of 21.5 weeks [15]. Here, ID1 is linked to T-cell non-Hodgkin lymphoma.